<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIM: Gene rearrangement has an important role in the management of <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>We investigated the rearrangements of B-cell <z:mpath ids='MPATH_336'>leukaemia</z:mpath>/<z:hpo ids='HP_0002665'>lymphoma</z:hpo> 2 (BCL2), BCL6 and Paired homeobox 5 (PAX5) genes in Indonesian follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (FL) patients </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: We examined gene rearrangements using various kinds of polymerase chain reactions (PCRs) on 24 patients' peripheral blood DNA </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: BCL2 rearrangement was found in 58% (14 of 24 patients), 8 at mbr (major breakpoint region), 2 at mcr (minor cluster region) and 4 at icr (intermediate cluster region), respectively </plain></SENT>
<SENT sid="4" pm="."><plain>No rearrangement in BCL6 and PAX5 was detected </plain></SENT>
<SENT sid="5" pm="."><plain>There was a significant difference in the incidence of spleen involvement between patients with BCL-2 rearrangement and without it (50% vs. 11%, p=0.04) </plain></SENT>
<SENT sid="6" pm="."><plain>BCL-2 rearrangement was correlated with spleen involvement (OR=9) and <z:hpo ids='HP_0001903'>anemia</z:hpo> (OR=2.3) </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSION: BCL2 rearrangement in Indonesian FL was higher than previous reports from other Asia countries (58% vs. 48%, respectively) </plain></SENT>
<SENT sid="8" pm="."><plain>Our method using peripheral blood DNA might be useful for the molecular diagnosis of FL </plain></SENT>
</text></document>